Compare YETI & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YETI | PBH |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 3.3B |
| IPO Year | 2016 | 2004 |
| Metric | YETI | PBH |
|---|---|---|
| Price | $36.68 | $63.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 4 |
| Target Price | $47.15 | ★ $80.75 |
| AVG Volume (30 Days) | ★ 1.5M | 358.7K |
| Earning Date | 05-21-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.88 |
| EPS | 2.03 | ★ 2.78 |
| Revenue | ★ $1,868,494,000.00 | $975,777,000.00 |
| Revenue This Year | $9.13 | N/A |
| Revenue Next Year | $7.16 | $2.15 |
| P/E Ratio | ★ $18.58 | $23.33 |
| Revenue Growth | 2.11 | ★ 36.77 |
| 52 Week Low | $26.61 | $57.25 |
| 52 Week High | $51.29 | $88.55 |
| Indicator | YETI | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 22.10 | 34.68 |
| Support Level | $34.81 | $62.84 |
| Resistance Level | $39.45 | $68.51 |
| Average True Range (ATR) | 1.56 | 1.71 |
| MACD | -0.83 | -0.72 |
| Stochastic Oscillator | 4.96 | 1.76 |
YETI Holdings Inc is a designer, marketer, and distributor of premium products for the outdoor and recreation market sold under the YETI brand. The company offers products including coolers and equipment, drinkware, and other accessories. Its trademark products include YETI Tundra, Hopper, YETI TANK, Rambler, Colster, Rambler among others. The company distributes products through wholesale channels and through direct-to-consumer, or DTC, channels.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.